Search

everythinglearnresearchcommunity

for

Search:↓

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Suppressing very long chain fatty acids is linked to skin cancer.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Fixing DNA errors is crucial to prevent skin cancer.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

HPV8 causes skin cancer by expanding specific skin stem cells.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Increasing SSAT makes skin more prone to cancer.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.